Akynzeo Capsule | One Capsule, Dual Protection
Akynzeo capsule is an FDA-approved antiemetic medication specifically designed to address both acute and delayed phases of chemotherapy-induced nausea and vomiting (CINV).
As chemotherapy remains a cornerstone of cancer treatment, its debilitating side effects – particularly nausea and vomiting – can significantly impact treatment adherence and patients’ quality of life.
CINV is clinically categorized into two distinct phases:
- Acute CINV: Occurs within the first 24 hours post-chemotherapy
- Delayed CINV: Develops 25-120 hours after treatment and may persist for several days
What makes Akynzeo unique is its dual-mechanism formulation that provides comprehensive, long-lasting relief for both phases. This innovative antiemetic combines two powerful medications in a single dose, offering patients more complete protection compared to traditional single-mechanism alternatives.
In the following sections, we’ll examine:
โข Akynzeo’s novel mechanism of action
โข Its demonstrated clinical efficacy
โข Practical considerations for patients and providers
โข Important safety information
๐ What Is Akynzeo Capsule?
It is a dual-action antiemetic that combines two powerful drugs to provide extended protection against CINV:
- Palonosetron โ A 5-HT3 receptor antagonist that blocks nausea and vomiting signals in the gut and brain. It is particularly effective in preventing acute-phase symptoms (first 24 hours after chemotherapy).
- Netupitantย โ Aย NK1 receptor antagonistย that targetsย substance P, a key neurotransmitter involved in delayed nausea and vomiting (days 2โ5 post-chemo).
Traditional antiemetics often target only one of these pathways, leaving patients vulnerable to breakthrough symptoms. Akynzeoโs dual-mechanism approach provides comprehensive, long-lasting protection against both phases, reducing the need for multiple medications.
๐How Effective Is Akynzeo Capsule?
Clinical trials involving 1,720 cancer patients undergoing moderate-to-high emetogenic chemotherapy (e.g., cisplatin, carboplatin, doxorubicin) demonstrated itโs superior efficacy compared to other treatments:
- Acute Phase (0โ24 hours):
- 98.5% of patients had no vomiting (vs. 89.7% with Aloxi alone).
- 93% experienced no significant nausea (vs. 85% with standard therapy).
- Delayed Phase (25โ120 hours):
- 90.4% remained vomit-free (vs. 80.1% with Aloxi).
- 85% reported minimal nausea (vs. 75% with older antiemetics).
These results highlight itโs ability to provide longer-lasting protection compared to traditional 5-HT3 blockers alone.
๐ฃ๏ธWho Can Benefit from Akynzeo Capsule?
Akynzeo is recommended for:
โ Patients starting moderate-to-high emetogenic chemotherapy (e.g., cisplatin, carboplatin, cyclophosphamide).
โ Those who have experienced delayed nausea/vomiting in past treatments.
โ Individuals seeking a single-dose solution instead of multiple antiemetics.
It is not typically used for low-emetogenic chemo (e.g., vinca alkaloids, taxanes) unless the patient has a history of severe CINV.
โ ๏ธ Potential Side Effects
While Akynzeo is generally well-tolerated, some patients may experience mild side effects, including:
- Headache (10โ15% of patients)
- Constipation (8โ12%)
- Fatigue (5โ10%)
- Dizziness (rare)
โฐHow and When to Take Akynzeo Capsule
โ Recommended Dosage
- Capsules: One 300 mg/0.5 mg capsule taken approximately one hour before starting chemotherapy.
- Injection: Administered by a healthcare professional as a 30-minute intravenous infusion, also one hour before chemotherapy.
๐ Administration Tips
โ Can be taken with or without food.
โ If prescribed dexamethasone, follow your doctorโs instructions carefully.
โ Do not take a second dose within 7 days unless directed.
Akynzeo can be taken with or without food. It’s important to follow your doctor’s instructions regarding any additional medications, such as dexamethasone, which may be prescribed alongside Akynzeo.
๐ง Important Considerations
- Pregnancy and Breastfeeding: Akynzeo is not recommended during pregnancy or breastfeeding.
- Driving and Operating Machinery: Akynzeo may cause dizziness or fatigue. If you experience these effects, avoid driving or operating heavy machinery.
- Drug Interactions: Inform your doctor about all medications you’re taking, including antidepressants, as interactions can occur.
๐About DengYueMed โ HK Drug Wholesale Distributor
As a legally compliant drug import and export company, DengYueMed is certified by the pharmacy & poisons board of Hong Kong โ you can verify our qualification on their official website.
hongkong drugoffice gov approved
Our efforts to improve the affordability of Akynzeo drug aim to ensure that more patients can benefit from this important medication.
HK DengYue provides detailed medicine information, transparent pricing, and responsive support to ensure a smooth and reliable buying experience.
Feel free to reach out anytime to discuss your needs or ask questions about the medicine.
We welcome you to contact us for a consultation.
